Autolus Therapeutics plc 8-K

What Happened

• Autolus Therapeutics plc announced on June 5, 2026 that it published its UK Annual Report and Accounts for the year ended December 31, 2025 and distributed the notice of its Annual General Meeting (AGM) to be held on June 29, 2026, together with a form of proxy to ordinary shareholders. The company furnished the Annual Report and AGM materials as exhibits to its Form 8‑K filed June 9, 2026.
• On or about June 8, 2026 Citibank, N.A., acting as depositary for Autolus’s American Depositary Shares (ADSs), began mailing notice materials and voting cards to ADS holders to enable holders of record as of May 27, 2026 to instruct the depositary how to vote the underlying ordinary shares.

Key Details

• Annual Report covers year ended December 31, 2025; AGM scheduled for June 29, 2026.
• ADS record date for voting instructions: May 27, 2026; depositary mailings commenced on or about June 8, 2026.
• Citibank, N.A. will attempt to vote ordinary shares in accordance with timely ADS holder instructions but may be limited by practical or legal constraints and timing of returned instructions.
• Depositary mailings include a link to Autolus’s website where ADS holders can view the AGM notice and the UK Annual Report.

Why It Matters

• Ordinary shareholders and ADS holders need to review the AGM materials and, if they want their ADSs voted at the AGM, submit timely voting instructions to the depositary (Citibank). Delays or legal/practical limits could prevent depositary voting as instructed.
• The filing supplies the company’s full 2025 Annual Report and AGM agenda for investors to assess governance, board proposals and company disclosures; the 8‑K does not announce earnings, management changes, or other material transactions.